HeadofState Diplomacy Strengthens ChinaRussia Partnership as Putins Visit Nears AI Accelerates New Business Formation Gen Z Entrepreneurs Lead the Charge Gusto Report NIP Group NIPG Q2 2025 Disappoints EPS 208 Below 021 Views IMF Upgrades UK Growth Forecast for 2026 But Warns Risks Remain Dow Jones Rallies to a Record High as Middle East Peace Hopes Fuel Market Optimism Potential TwoDay Strike Could Disrupt State Bank of India Branch Services on May 2526 Trump Indicates Potential Iran Deal to Reopen Strait of Hormuz Rubio Confirms Progress Golds Risk Premium May Remain Compressed Limiting NearTerm Breakout Potential General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range Vegorama Punjabi Angithi Shares Surge 53 on Market Debut Hit Upper Circuit Unum Group Q1 2026 Earnings Solid EPS Beat Amid Steady Performance MT Bank Q1 2026 Earnings EPS Beats Estimates by 2 as Shares Edge Higher Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending GWRE Q1 2026 Earnings EPS Beat Sparks 335 AfterHours Surge BLX Q1 2026 Earnings Earnings Per Share Reported at 131 Shares Dip 227 RNTX Q1 2026 Earnings Narrowerthanexpected Loss Fails to Lift Shares Sable Offshore Corp SOC Edges Higher as Shares Approach Key Resistance CION Investment Notes CICB Edge Lower as Bond Yields Compress Strive Inc ASST Slips 204 as Shares Test Key Support Near 1684 AgEagle Aerial Systems UAVS Holds at 100 After Modest Gain Key Support and Resistance in Focus Pembina Pipeline PBA Sheds 148 as Pipeline Sector Faces ProfitTaking Pressure Chicago Rivet Machine Co CVR Q3 2023 Earnings Narrowing Loss and Modest Stock Recovery Signal Caution Burlington Stores BURL Q1 2026 Earnings EPS Beats Estimates Amid Modest Sales Performance Nortech Systems NSYS Q3 2025 Earnings Loss Per Share Reported Amid Modest Stock Gain KOF Q1 2026 Earnings EPS Misses Estimates by 152 Stock Declines LCUT Q1 2026 Earnings A Stunning EPS Surprise Drives Shares Higher Surge in Treasury Yields Reshapes Bond Market Landscape Investors Seek New Opportunities Adaptive Biotechnologies ADPT Q1 2026 Earnings Narrower Loss Beats Consensus Shares Edge Lower Aprea Therapeutics APRE Gains 278 as Shares Approach Key Resistance at 099